Amgen Cash Flow Statement

AMGN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)

Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.

At a glance

Operating Cash Flow

$10.0B

FY2025

Free Cash Flow

$8.1B

FY2025

Capital Expenditures

$1.9B

Cash used for long-term assets

Dividends Paid

$5.1B

FY2025

New to cash flow statements? Read the quick guide.

Amgen generated $10.0B in operating cash flow and $8.1B in free cash flow in FY2025. Free cash flow margin was 22.0% of revenue.

Based on SEC 10-K filings.

Key Data Points

Altman Z-Score NaN (distress zone, below 1.23 threshold)
High leverage: Debt-to-equity ratio of 6.31
Profit margin: 21.0% of revenue retained as profit

Data sourced from SEC EDGAR filings. Not investment advice.

Item	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Net Income	$7.7B	$4.1B	$6.7B	$6.6B	$5.9B	$7.3B	$7.8B	$8.4B	$2.0B	$7.7B	$6.9B	$5.2B	$5.1B	$4.3B	$3.7B
Depreciation & Amortization	$5.2B	$5.6B	$4.1B	$3.4B	$3.4B	$3.6B	$2.2B	$1.9B	$2.0B	$2.1B	$2.1B	$2.1B	$1.3B	$1.1B	$1.1B
Operating Cash Flow	$10.0B	$11.5B	$8.5B	$9.7B	$9.3B	$10.5B	$9.2B	$11.3B	$11.2B	$10.4B	$9.7B	$9.0B	$6.3B	$5.9B	$5.1B
Capital Expenditures	$1.9B	$1.1B	$1.1B	$936.0M	$880.0M	$608.0M	$618.0M	$738.0M	$664.0M	$738.0M	$594.0M	$718.0M	$693.0M	$689.0M	$567.0M
Free Cash Flow	$8.1B	$10.4B	$7.4B	$8.8B	$8.4B	$9.9B	$8.5B	$10.6B	$10.5B	$9.6B	$9.1B	$8.2B	$5.6B	$5.2B	$4.6B
Share Buybacks	$0	$200.0M	$0	$6.4B	$5.0B	$3.5B	$7.7B	$17.8B	$3.2B	$3.0B	$1.9B	$138.0M	$832.0M	$4.6B	$8.3B
Dividends Paid	$5.1B	$4.8B	$4.6B	$4.2B	$4.0B	$3.8B	$3.5B	$3.5B	$3.4B	$3.0B	$2.4B	$1.9B	$1.4B	$1.1B	$500.0M
FCF Margin	22.0%	31.1%	26.1%	33.4%	32.3%	38.9%	36.5%	44.5%	46.0%	41.8%	42.2%	41.0%	30.0%	30.1%	29.2%

Other Financial Statements

Income Statement Balance Sheet All Financial Data

Scores & Analysis

Piotroski F-Score Altman Z-Score Financial Ratios

Amgen Profile All Financial Data

Item

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

Net Income

$7.7B

$4.1B

$6.7B

$6.6B

$5.9B

$7.3B

$7.8B

$8.4B

$2.0B

$7.7B

$6.9B

$5.2B

$5.1B

$4.3B

$3.7B

Depreciation & Amortization

$5.2B

$5.6B

$4.1B

$3.4B

$3.6B

$2.2B

$1.9B

$2.0B

$2.1B

$1.3B

$1.1B

Operating Cash Flow

$10.0B

$11.5B

$8.5B

$9.7B

$9.3B

$10.5B

$9.2B

$11.3B

$11.2B

$10.4B

$9.7B

$9.0B

$6.3B

$5.9B

$5.1B

Capital Expenditures

$1.9B

$1.1B

$936.0M

$880.0M

$608.0M

$618.0M

$738.0M

$664.0M

$738.0M

$594.0M

$718.0M

$693.0M

$689.0M

$567.0M

Free Cash Flow

$8.1B

$10.4B

$7.4B

$8.8B

$8.4B

$9.9B

$8.5B

$10.6B

$10.5B

$9.6B

$9.1B

$8.2B

$5.6B

$5.2B

$4.6B

Share Buybacks

$200.0M

$6.4B

$5.0B

$3.5B

$7.7B

$17.8B

$3.2B

$3.0B

$1.9B

$138.0M

$832.0M

$4.6B

$8.3B

Dividends Paid

$5.1B

$4.8B

$4.6B

$4.2B

$4.0B

$3.8B

$3.5B

$3.4B

$3.0B

$2.4B

$1.9B

$1.4B

$1.1B

$500.0M

FCF Margin

22.0%

31.1%

26.1%

33.4%

32.3%

38.9%

36.5%

44.5%

46.0%

41.8%

42.2%

41.0%

30.0%

30.1%

29.2%